|
Re: More Than Just DSMB Green Light
|
4
|
Resverlogix Corp.
|
Nov 01, 2017 01:36PM
|
|
Re: My best guess on the orphan indication....
|
4
|
Resverlogix Corp.
|
Jul 15, 2015 07:30PM
|
|
Re: My conversation with Don....
|
2
|
Resverlogix Corp.
|
Dec 02, 2017 09:15AM
|
|
Re: My email re the new website:
|
4
|
Resverlogix Corp.
|
Nov 23, 2017 01:27PM
|
|
Re: My latest email to IR....
|
6
|
Resverlogix Corp.
|
Apr 16, 2019 06:09PM
|
|
Re: My latest email to IR....
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 07:16PM
|
|
Re: My one-minute commercial for Apabetalone
|
7
|
Resverlogix Corp.
|
Sep 10, 2019 09:12PM
|
|
Re: My Rant - Limited attendance AGM, one way communication, vetted questions
|
1
|
Resverlogix Corp.
|
Jun 21, 2022 11:07AM
|
|
Re: Nasdaq listing -- Awesome News!!
|
7
|
Resverlogix Corp.
|
Aug 01, 2018 01:53PM
|
|
Re: Nasdaq listing -- Awesome News!!
|
6
|
Resverlogix Corp.
|
Jul 31, 2018 05:49PM
|
|
Re: Nasdaq listing -- Awesome News!!
|
3
|
Resverlogix Corp.
|
Jul 31, 2018 06:12PM
|
|
Re: National Research Council's financially supported companies for COVID and LONG COVID
|
4
|
Resverlogix Corp.
|
Dec 09, 2022 12:01PM
|
|
Re: New blog entry: Disrupting Treatment of Cardiovascular Disease with Epigenetics
|
5
|
Resverlogix Corp.
|
Aug 29, 2015 03:32PM
|
|
Re: New blog posting about RVX...
|
2
|
Resverlogix Corp.
|
Sep 11, 2016 08:16AM
|
|
Re: New Deal premium to market ...
|
5
|
Resverlogix Corp.
|
Mar 25, 2016 12:26PM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 10, 2022 07:19AM
|
|
Re: New paper
|
6
|
Resverlogix Corp.
|
Mar 19, 2023 11:52AM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
4
|
Zenith Epigenetics
|
Mar 03, 2017 10:01AM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
2
|
Zenith Epigenetics
|
Mar 03, 2017 11:04AM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
3
|
Zenith Epigenetics
|
Mar 03, 2017 01:25PM
|
